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Abstract:  Thyroid dysplasia was recognized in WistarHan GALAS rats and confirmed as a heritable congenital
disorder.  The gene or genes involved were not identified, but homozygous animals with thyroid dysplasia also exhibited
stunted growth, had reduced pituitary gland growth hormone (GH) and were hypothyroid.  Heterozygous animals
exhibited thyroid dysplasia with normal thyroid hormonal homeostasis and no difference in the incidence of
preneoplastic or neoplastic lesions in oncogenicity studies. (J Toxicol Pathol 2009; 22: 247–254)
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Introduction
In 1997, it was noted that approximately 25% of the
offspring of the Hannover Wistar GALAS rats derived from
BRL Füllinsdorf were affected by thyroid lesions, had
growth retardation, were hypothyroid however the pituitary
growth hormone could not be demonstrated by
immunohistochemistry.  Similarly, studies in other
companies, including the breeders of the GALAS program,
were affected by this same lesion.  The probable genetic
origin as well as the histological details, led to the term
‘thyroid gland dysplasia’.  The lesion was initially presented
at the GTP Seminar at Zürich in 1998.  In spring 1999 it was
decided between RCC Ltd and the members of the GALAS
program to institute a selective breeding and culling program
for the colony in order to completely eradicate the thyroid
alteration from the RCC breeding colony by 2000.  In 2001,
a vacuolar change in the thyroid follicular cells rats
representing the same lesion as well as dwarfism in GALAS
were reported1,2.  Furthermore, bone characteristics were
described in dwarfs derived from GALAS rats3.
Material and Methods
Procedures performed at Schering AG, Berlin 
Selected litter mates, dwarfs and normal stature animals
of the same litters were euthanatized at approximately 8–9
weeks of age.  Blood samples were collected at necropsy and
serum levels of T3, T4 and TSH were measured.  by the
following method.  Serum levels of T3, T4 and TSH were
using commercially available EIA kits (for TSH: Amersham
Pharmacia Biotech code RPN 2564; for T3: Biomerica code
No. 7013; for T4: Biomerica code No. 7012).
The thyroid glands were collected, weighed, fixed in
4% neutral phosphate-buffered formaldehyde solution,
trimmed, processed, embedded in paraffin wax, cut at an
approximate thickness of 4 μm, stained by haematoxylin and
eosin, and examined by light microscopy.
Selected paraffin sections of enlarged thyroid glands of
dwarfs and normal stature litter mates as well as litter mates
without any gross lesion were stained with antibodies against
growth hormone (hGH) and thyroidglobulin (TGH).
Briefly, polyclonal antibodies Anti-Growth hormone
(Catalog No. AR028-5R, Clone No. PU028-UP, BioGenex,
dilution of 1:100) and Rabbit Anti-Human Thyroglobulin
antibodies (Code No. A 0251, Lot 096, DAKO, dilution
1:8000 over night) were used on phosphate-buffered
formaldehyde fixed material, embedded in paraffin wax, and
cut at a nominal thickness of 4 μm.  For detection,
DakoCytomation EnVision+ System-HRP (DAB) was used
according to the test kit description.
Enlarged thyroid glands of dwarfs and normal stature
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litter mates as well as litter mates without any gross lesion
were also sampled and fixed in 5% phosphate buffered
glutaraldehyde for examination by transmission electron
microscopy.
Selective breeding and culling procedures
At RCC Itingen, Switzerland, all pups from parental
WistarHan GALAS rat breeder pairs 141 and 46 and three
randomly selected pups of 250 parental WistarHan GALAS
rat pairs, respectively, underwent necropsy at approximately
5 to 6 weeks of age to determine the presence of the ‘thyroid
gland dysplasia’.  The thyroid glands were collected, fixed in
4% neutral phosphate-buffered formaldehyde solution,
trimmed, processed, embedded in paraffin wax, cut at an
approximate thickness of 4 μm, stained by haematoxylin and
eosin, and examined by light microscopy.  This procedure
was performed during three sequential screenings of animals
on 119, 44 and 36 parental WistarHan GALAS rat breeder
pairs, respectively.
Hormone study at RCC
Twenty five offspring per sex of selected breeding
pairs, known to transmit the disease, were selected at 6–8
weeks of age and maintained for 13 weeks under optimal
hygienic standard conditions.  Blood samples were collected
on days 1, 28 and 90.  Serum levels of T3, T4 and TSH were
using commercially available EIA kits (for TSH: Amersham
Pharmacia Biotech code RPN 2564; for T3: Biomerica code
No. 7013; for T4: Biomerica code No. 7012).  Histologic
examination was performed on the thyroid glands of all
animals.
Hormone study at participating Swiss company
One hundred and fifty offspring per sex were randomly
selected at approximately 4 weeks of age and maintained for
14 weeks under specified pathogen free standard laboratory
conditions.  Blood samples were collected at weeks 5 and 14.
Plasma levels of T3, T4 and TSH were measured using
commercially available EIA kits (for TSH: Amersham
Pharmacia Biotech code RPN 2564; for T3: Biomerica code
No. 7013; for T4: Biomerica code No. 7012).  The thyroid
glands of all animals were examined histologically using
standard light microscopy.
Results
Mechanistic study at Schering AG, Berlin 
The thyroid glands were enlarged and absolute and
relative organ weights were increased.  At light microscopy
Fig. 1. Enlarged thyroid follicle cells with apically placed nuclei
located on a subcellular structure (colloid-containing vesicle).
Tissues stained with hematoxylin and eosin. Lens ×20.
Fig. 2. Both animals are of the same litter.  Note marked growth
retardation.
Fig. 3. Electron micrograph of thyroid follicle from control animal.Weber, Ernst, Fankhauser et al. 249
examination of enlarged thyroid glands, there was a diffuse,
rarely focal or multifocal change consisting of enlarged
follicle cells which typically had apically placed nuclei
located on a subcellular structure (colloid-containing
vesicle) (Fig. 1).  The incidence of affected animals in 3
litters was: 5 dwarfs (22%), 12 normal growing animals with
thyroid dysplasia (52%) and 6 unaffected littermates (26%)
(Fig. 2).  By electron microscopy, in dwarfs as well as
Fig. 4. Electron micrograph of thyroid follicle from dwarf rat.
Thyroid dysplasia is evident by dilated basally located rough
endoplasmic reticulum displacing the nucleus to an apical
position.  The apically located endoplasmic reticulum is not
affected.
Fig. 5. Electron micrograph of thyroid follicle from normal growing
animal with thyroid dysplasia.  A similar ultramorphological
change as noted in dwarf rats is evident.
Fig. 6. Electron micrograph of thyroid follicle from dwarf rat.
Higher magnification of Fig. 4.  The dilated structure is rough
endoplasmic reticulum.
Fig. 7. Electron micrograph of thyroid follicle from normal growing
animal with thyroid dysplasia.  Higher magnification of Fig.
5.  No other structures than endoplasmic reticulum are
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normal growing animals with thyroid dysplasia, the basally
located rough endoplasmic reticulum was dilated and
displaced the normally basally located nucleus to an apical
position.  The apically located endoplasmic reticulum was
not affected (Figs. 3–7).
Dwarfs with reduced body weights (less than one third
of littermates) showed features of a dysplastic thyroid gland,
a 6–8 fold increase in serum TSH levels along with a severe
decrease of T4 leading to abnormal TSH/T4 ratios
(hypothyroid).  In contrast, animals showing normal growth
with dysplastic thyroid glands appeared to be normal for
both TSH and T4 (euthyroid) (Table 1).  There was no
difference in TSH-levels in the pituitary glands of dwarfs
compared to the animals with normal growth using
immunohistochemistry.  GH-levels in the pituitary glands of
dwarfs were remarkedly reduced when compared to animals
with normal growth and no difference was seen between
normal growing animals with thyroid dysplasia and
unaffected animals (Figs. 8–9).
Regarding TGH, in follicle epithelia of dwarfs, there
was a clumpy inmunohistochemical reaction product.  In
generally smaller follicles, the reactivity was irregular or
missing.  In contrast, in the follicle cell cytoplasm of control
animals, the reaction product took the form of fine droplets,
and within the follicular colloid it was fine disperse.  In
heterocygotes, both aforementioned reactivity patterns were
found (Figs. 10–12).
Table 1. Summarized Results of Mechanistic Study Performed at Schering AG, Berlin
Feature BW (g) Sex Thyroid GH TSH TSH T4 TSH/T4
feature stain stain (μg/ l) (nmol/l)
dwarf 36.0 F dysplastic ↓↓↓ normal 6777 1 6777
dwarf 32.7 F dysplastic ↓↓↓ normal 5371 2 2685
normal 151.8 F dysplastic normal normal 731 34 21.5
normal 148.8 F dysplastic normal normal 225 35 6.4
normal 147.3 F dysplastic normal normal 664 47 14.1
normal 149.7 F dysplastic normal normal 568 44 12.9
normal 216.7 M dysplastic normal normal 473 75 6.3
normal 229.3 M dysplastic normal normal 2594 45 57.6
normal 150.7 F normal normal normal 87 31 2.8
normal 135.2 F normal normal normal 403 46 8.8
normal 147.3 M normal normal normal 705 31 22.7
All pups of the same litter.
Fig. 8. Immunohistochemical localization of Growth Hormone
(hGH) in a control rat pituitary gland.  Many cells reacting
positively.  hGH antibody was obtained from BioGenex
(USA).  Secondary HRP-conjugated anti-mouse antibody was
obtained from Dako (Germany).
Fig. 9. Immunohistochemical localization of Growth Hormone
(hGH) in a dwarf rat pituitary gland.  Only a few cells
reacting positively.  hGH antibody was obtained from
BioGenex (USA).  Secondary HRP-conjugated anti-mouse
antibody was obtained from Dako (Germany).Weber, Ernst, Fankhauser et al. 251
Results obtained by selective breeding and culling
procedures in GALAS colonies
At RCC Itingen, three sequential screenings with
subsequent culling and selective breeding were performed to
eliminate the undesirable traits of thyroid dysplasia and
stunted growth from the colony.  In the first screening, all
pups from 141 litters were evaluated, whereby 28 (19.6%) of
the litters were affected.  The incidence of this lesion ranged
within littermates between 12.5 and 64.0%.  After rotation
breeding, in the second screening, three randomly selected
pups of 250 litters were evaluated.  Three (1.2%) of the
litters were affected.  Therefore, after a next rotation
breeding, all pups of 46 litters were examined and no case of
thyroid gland dysplasia was recorded.
The following incidences were recorded at histology for
other GALAS breeders: Breeder 1: 9 (7.6%) of 119 litters
were affected with an incidence within the litters of 25.0%–
75.0%; Breeder 2: 10 (22.7%) of 44 litters were affected with
an incidence within the litters of 6.7%–100.0%; Breeder 3: 6
(16.7%) of 36 litters were affected with an incidence within
the litters of 36.5.0%–67.0%.
Hormone studies
In thyroid hormone studies of 13 weeks duration
performed both at RCC Ltd and at an agrochemical company
showed that there were no relevant differences in TSH, T3
and T4 levels between normal control animals (not
exhibiting thyroid dysplasia) and normally growing,
dysplastic animals (Tables 2 and 3).  More generally, the
study of the agrochemical company showed that there were
no in-life parameters that could indicate the presence or
absence of the condition of thyroid dysplasia.
Discussion
In 1997, a spontaneous lesion was detected in the
thyroid glands of approximately 25% of the offspring of a
Fig. 10. Immunohistochemical localization of Thyroglobulin (THG)
in a control rat thyroid gland.  THG appears in form of fine
droplets within the follicular epithelium and is fine disperse
within the follicular colloid.  TGH antibody as well as
secondary HRP-conjugated anti-mouse antibody were
obtained from Dako (Germany).
Fig. 11. Immunohistochemical localization of Thyroglobulin (THG)
in a dwarf rat thyroid gland.  THG-reactivity appears to be
clumpy within follicular epithelia.  Follicles are generally
smaller as in controls and immunohistochemical reactivity
is irregular or missing.  TGH antibody as well as secondary
HRP-conjugated anti-mouse antibody were obtained from
Dako (Germany).
Fig. 12. Immunohistochemical localization of Thyroglobulin (THG)
in a heterozygote rat thyroid gland.  THG-reactivity patterns
are intermediary of those demonstrated for controls or
dwarf rats. TGH antibody as well as secondary HRP-
conjugated anti-mouse antibody were obtained from Dako
(Germany).252 Thyroid Dysplasia in GALAS Rats
WistarHan: Brl (GALAS) rat colony at Schering AG, Berlin.
The thyroids were enlarged and absolute and relative organ
weights were increased.  There was no clinical or
biochemical alteration.  However, well proportioned,
hypothyroid dwarfs with GH-cell hypoplasia in the pituitary
gland were also encountered in isolated litters.  A similar
lesion had been detected in 1996 in a satellite group of 50
young Wistar rats (12–13 weeks of age) from an
oncogenicity study that were histologically examined at
RCC Itingen in Switzerland.  In the high dose group,
treatment-related hepatocellular hypertrophy accompanied
by an uncommon type of diffuse follicular hypertrophy in
the thyroid gland was noted.  Since there is a known
relationship between both findings, i.e. increased turnover of
Table 2. Serum Levels for T3, T4 and TSH in 25 Offsprings Per Sex of Selected Parental Animals
Males Animals without dysplasia Animals with dysplasia
T3 (nmol/l) T4 (nmol/l) TSH (μg/ l) T3 (nmol/l) T4 (nmol/l) TSH (μg/ l)
Day 1 n 12 12 12 13 13 13
Mean 0.84 37.4 7.21 0.75 38.44 6.32
Stand.Dev. 0.18 11.07 1.92 0.17 5.49 2.48
Day 28 n 12 12 12 13 13 13
Mean 0.83 34.33 7.65 0.76 41.26 5.91
Stand.Dev. 0.12 14.91 3.15 0.10 5.31 1.43
W e e k  1 3 n 1 2 1 21 2 1 3 1 31 3
Mean 0.86 30.42 6.91 0.83 42.31 5.53
Stand.Dev. 0.14 13.42 1.73 0.12 15.40 1.92
Females Animals without dysplasia Animals with dysplasia
T3 (nmol/l) T4 (nmol/l) TSH (μg/ l) T3 (nmol/l) T4 (nmol/l) TSH (μg/ l)
Day 1 n 13 13 11 12 12 10
Mean 0.97 24.27 9.28 0.98 30.42 6.36
Stand.Dev. 0.22 7.41 2.64 0.15 13.38 1.76
Day 28 n 13 13 12 12 12 12
Mean 0.85 28.05 11.77 0.88 32.65 7.82
Stand.Dev. 0.09 6.66 3.67 0.17 12.28 1.37
W e e k  1 3 n 1 3 1 31 2 1 2 1 21 2
Mean 0.94 29.33 8.69 1.01 32.44 6.85
Stand.Dev. 0.19 9.58 2.31 0.26 8.91 1.29
Study performed at RCC Ltd Itingen, Switzerland.
Table 3. Serum Levels for T3, T4 and TSH in 140 Offsprings Per Sex of Randomly Selected Parental Animals
Males Animals without dysplasia Animals with dysplasia
T3 (nmol/l) T4 (nmol/l) TSH (μg/ l) T3 (nmol/l) T4 (nmol/l) TSH (μg/ l)
Week 5 n 128 128 128 21 21 21
Mean 1.46 101.5 13.16 1.33 96.4 13.66
Stand.Dev. 0.31 12.1 2.46 0.26 10.1 2.45
Week 14 n 128 128 128 21 21 21
Mean 1.65 102.7 12.70 1.77 101.5 12.98
Stand.Dev. 0.49 15.5 2.74 0.51 15.9 2.42
Females Animals without dysplasia Animals with dysplasia
T3 (nmol/l) T4 (nmol/l) TSH (μg/ l) T3 (nmol/l) T4 (nmol/l) TSH (μg/ l)
Week 5 n 132 132 132 18 18 18
Mean 1.68 86.2 12.27 1.54 78.30 12.71
Stand.Dev. 0.57 16.7 3.33 0.38 16.80 3.96
Week 14 n 132 132 132 18 18 18
Mean 1.46 75.7 13.94 1.49 76.10 14.39
Stand.Dev. 0.42 15.1 2.62 0.57 15.40 3.08
Study performed at participating Swiss company.Weber, Ernst, Fankhauser et al. 253
hormones by higher metabolic activity of the liver leading to
hepatocellular hypertrophy and following adaptive response
of the thyroids, i.e. follicular hypertrophy, the lesion was
considered to be treatment-related.  However, the thyroid
gland findings were also seen in some control animals.  After
this 1996 study, follicular hypertrophy of the thyroid gland
was noted in most studies, randomly distributed over all
groups including the controls.  From a retrospective
evaluation, the first case appeared in RCC studies in 1995.
As mentioned above, approximately 25% of the
offspring were affected by thyroid lesions along with growth
retardation in single litter mates.  The latter were
hypothyroid and the pituitary growth hormone could not be
demonstrated by immunohistochemistry.  Within one litter,
there were dwarfs, animals with normal body size along with
thyroid dysplasia and unaffected animals (selected litters: 5
dwarfs, 12 normal growing animals with thyroid dysplasia, 6
normal animals, i.e. approximately 22%, 52% and 26%,
respectively).  Animals with normal growth patterns had no
clinical or biochemical abnormalities including those with
thyroid lesions.  In contrast, dwarfs with growth retardation
showed an almost complete lack of pituitary GH reactivity,
reached half the size of the normal litter mates, and a high
proportion of these animals displayed continuous abnormal
hopping movements.
TGH in thyroid glands showed abnormalities when
examined by immunohistochemistry consisting of a clumpy
inmunohistochemical reaction product in follicle epithelia
and an irregular or missing reactivity in follicular colloid of
dwarfs, whereas different reaction patterns were recorded in
normal growing rats with thyroid dysplasia.
Neonatal hypothyroidism is known to be associated
with a significant decrease in pituitary GH content4.  In rats,
GH cells first appear on day 18 of gestation.  The synergism
of glucocorticoid and thyroid hormones in the GH
expression is described.  Thyroid hormone exert a
stimulatory effect on GH expression in the fetal pituitary
gland.  The fetal thyroid hormone level is low until the onset
of fetal thyroid function, which occurs between days 17 and
18 of gestation.  The action on GH expression is evident as
early as day 17 of gestation in rats5.  Therefore, it is
concluded that also in the present alteration thyroid hormone
levels directly influenced pituitary GH leading to the
appearance of dwarfs.  The cause of dwarfism by primary
hypothyroidism in GALAS rats was also considered by
others2.  It may be assumed that protein folding and secreting
disorders underlie the hypothyroidism similar to the
mechanism described for rdw rats6.
The morphological alteration noted by light microscopy
included diffuse, rarely focal or multifocal change,
consisting of enlarged follicle cells which typically have
apically placed nuclei located on a subcellular structure
(colloid-containing vesicle).  The subcellular structure was
identified by electron microscopy as dilated endoplasmic
reticulum that has displaced the normally basally located
nucleus.  Only the basally located endoplasmic reticulum
structures became dilated, in contrast to the apical portion
leading to the assumption of a polar affection of cell
organelles.  Lesions described elsewhere1–3 in GALAS rats
were consisted with these alterations.
Despite the lack of growth hormone in the pituitary
demonstrated by immunohistochemistry as well as a 3–5
fold increase in serum TSH levels along with a severe
decrease of T4 leading to pathological TSH/T4 ratios
(hypothyroid) in dwarfs, a morphological difference in the
thyroid glands between dwarfs and normal sized animals
with thyroid dysplasia could not be detected.
The proportion of dwarfs, normal size animals with
thyroid dysplasia, and unaffected animals at a relation of
approximately 1:2:1 led to the assumption of an autosomal
recessive hereditary disorder.
These findings gave rise to the possibility that normal
sized animals with thyroid dysplasia may react differently
than normal animals in toxicity studies.  Problems that could
arise include increased tumor incidences, exaggerated
reactions to weak goitrogens or secondary to hepatocellular
hypertrophy.  It was also unclear if the hormonal status
changed with increasing age.  Moreover, animals suffering
from this hereditary disorder which produce a high number
of dwarfs are not suitable for reprotoxicity studies.
Therefore, it was proposed to all GALAS members that
a histological examination of the thyroid glands from all
pups of numbered breeding pairs be performed at RCC
Itingen, Switzerland.  All littermates would receive the
number of the breeder parents.  All parental breeding pairs
that had affected pups, would be eliminated from further
breeding.  The remaining parental animals would be bred
crossover for a further search for thyroid-dysplasia gene
bearers.  RCC Ltd performed this procedure in three steps.
In RCC litters, the incidence of this lesion ranged within
littermates between 12.5 and 64.0%.  From 2000 onwards,
no new case of this disorder has been detected.  Only a
selected number of litters were examined from all other
GALAS breeders showing a similar incidence of lesions
within their colonies (7.6%–22.7%) and litters (6.7%–
100%), respectively.  Hence, it is concluded that at the stage
when these investigations were performed, approximately
8.9% of all breeding animals of the GALAS colonies were
affected by the involved gene(s) assuming an incidence of
approximately 20% of affected litter mates (Hardy-
Weinberg: p2+2pq+q2=1 leading to a relation of 79.2%
normal animals : 19.6% normal sized but dysplastic animals:
1.2% dwarfs.  A total of approximately 98.8% of the litter
mates would appear to be normal.
In addition, hormone studies were performed to
establish the validity of studies already performed with such
animals.  A number of companies took part in this test, either
in cooperation with RCC or they performed in-house studies
by themselves.  In 13-week studies performed at RCC
Itingen, Switzerland, and independently also in a
agrochemical company, no changes could be detected in
levels of T3, T4 and TSH in normal growing animals with
thyroid dysplasia.  This result was confirmed by other
companies that performed similar in-house studies.254 Thyroid Dysplasia in GALAS Rats
Published data on T3, T4 and TSH in normal growing
animals were comparable1.  In addition, there was no
indication of increased preneoplastic and neoplastic lesions
in oncogenicity studies performed with normal sized but
thyroid dysplastic animals.
Summarized, thyroid dysplasia was recognized and
confirmed as congenital disorder.  It is hypothesized that
homozygotes are dwarfs in which a reduction of pituitary
gland GH, thyroid dysplasia and hypothyroidism is present.
Animals with normal growth but dysplastic thyroids were
not expressing higher incidences of pre-neoplastic or
neoplastic changes in the thyroid gland but are not suitable
for reprotoxicty studies because of the possibility of giving
birth to dwarfs.
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